NCT01977937View on ClinicalTrials.gov

Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Pain, Postoperative
Interventions
DRUG

Gabapentin 250mg/5mL NDC:59762-5025-01

DRUG

Simple Syrup

Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT01977937 - Pain Control in Pediatric Posterior Spine Fusion Patients: The Effect of Gabapentin | Biotech Hunter | Biotech Hunter